Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 03-2019 | 12-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,744 | -36 | N/A | -35 | N/A |
| Depreciation Amortization | 2,120 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,101 | N/A | N/A | N/A | N/A |
| Other Working Capital | -252 | 3 | N/A | 0 | N/A |
| Other Operating Activity | 2,236 | 0 | 0 | 0 | 0 |
| Operating Cash Flow | $-31,741 | $-33 | $N/A | $-35 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -466 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-466 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 38 | N/A | 35 | N/A |
| Common Stock Issued | N/A | N/A | N/A | 1 | N/A |
| Financing Cash Flow | $N/A | $38 | $N/A | $35 | $N/A |
| Beginning Cash Position | 57,773 | N/A | N/A | N/A | N/A |
| End Cash Position | 25,566 | 5 | N/A | N/A | N/A |
| Net Cash Flow | $-32,207 | $5 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,741 | -33 | N/A | -35 | N/A |
| Capital Expenditure | -466 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -32,207 | -33 | 0 | -35 | 0 |